Market revenue in 2023 | USD 359.4 million |
Market revenue in 2030 | USD 663.9 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Ceramics & bioactive glass biomaterials |
Fastest growing segment | Polymers Biomaterials |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.3% in 2023. Horizon Databook has segmented the Australia orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
Key factors anticipated to drive the market growth over the forecast period are growing prevalence of musculoskeletal disorders in the country. For instance, according to the statistics provided by the Australian Institute of Health and Welfare, 1 in 11 Australian reported osteoarthritis in 2017-2018. Also, 1 in 5 Australians aged 75 and over reported osteoporosis and osteopenia.
Moreover, back pain and other related symptoms were the second leading causes of overall disease burden in Australia in 2015. These facts signify that the prevalence of musculoskeletal conditions is high in the country. As the prevalence is high, demand for reconstruction and repair surgeries is anticipated to increase.
Furthermore, it has been analyzed that geriatric population suffering from knee osteoarthritis opt for viscosupplementation for pain reduction and smooth functioning of the knees. This is further anticipated to create a strong demand for orthopedic biomaterials such as hyaluronan or hyaluronic acid over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia orthopedic biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into Australia orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account